Successfully marketing clinical trial results winning in the healthcare business /

Innovation and the pharmaceutical industry critical reflections on the virtues of profit /
منشور في: (2008)

Clinical trials study design, endpoints and biomarkers, drug safety, FDA and ICH guidelines /
حسب: Brody, Tom
منشور في: (2012)

Clinical trials audit preparation a guide for good clinical practice (GCP) inspections /
حسب: Mihajlovic-Madzarevic, Vera
منشور في: (2010)

Clinical trials handbook
منشور في: (2009)

Clinical trials handbook design and conduct /
حسب: Meinert, Curtis L.
منشور في: (2012)

Pharmaceutical drug analysis methodology - theory - instrumentation - pharmaceutical assays - cognote assays.
حسب: Kar, Ashutosh
منشور في: (2005)

Statistical thinking for non-statisticians in drug regulation /
حسب: Kay, R. (Richard), 1949-
منشور في: (2015)

Binary data analysis of randomized clinical trials with noncompliance
حسب: Lui, Kung-Jong
منشور في: (2011)

Pharmaceutical toxicology in practice a guide for non-clinical development /
منشور في: (2011)

Drug discovery and design medical aspects /
منشور في: (2002)

Target validation in drug discovery
منشور في: (2006)

Modern biopharmaceuticals recent success stories /
منشور في: (2013)

Drugs and laboratory parameters
حسب: Caputi, Achille Patrizio
منشور في: (2010)

Control and the therapeutic trial rhetoric and experimentation in Britain, 1918-48 /
حسب: Edwards, Martin, 1955 Nov. 23-
منشور في: (2007)

Steal this urine test : fighting drug hysteria in America /
حسب: Hoffman, Abbie
منشور في: (1987)

An introduction to statistics in early phase trials
حسب: Julious, Steven A.
منشور في: (2010)

Clinical trials in psychopharmacology a better brain /
منشور في: (2010)

Predictive approaches in drug discovery and development biomarkers and in vitro/in vivo correlations /
منشور في: (2012)

Integrated cardiac safety assessment methodologies for noncardiac drugs in discovery, development, and postmarketing surveillance /
حسب: Turner, J. Rick
منشور في: (2009)

Classical and adaptive clinical trial designs using ExpDesign Studio [trademark symbol]
حسب: Chang, Mark
منشور في: (2008)

Accelerating the development of biomarkers for drug safety workshop summary /
منشور في: (2009)

Drug testing in law enforcement agencies social control in the public sector /
حسب: Brunet, James R., 1966-
منشور في: (2005)

Understanding drugs markets : an analysis of medicines, regulations, and pharmaceutical systems in the global south /
منشور في: (2022)

The world heroin market can supply be cut? /
حسب: Paoli, Letizia
منشور في: (2009)

Preclinical development handbook.
منشور في: (2008)

Digital transformations of illicit drug markets : reconfiguration and continuity /
حسب: Tzanetakis, Meropi, وآخرون
منشور في: (2023)

Regulating bioprospecting institutions for drug research, access, and benefit-sharing /
حسب: Sampath, Padmashree Gehl
منشور في: (2005)

Installation qualification of IBM systems and storage for FDA regulated companies
حسب: Bradburn, James R.
منشور في: (2003)

Outsourcing clinical development strategies for working with CROs and other partners /
منشور في: (2006)

Challenges for the FDA the future of drug safety : workshop summary /
منشور في: (2007)

Prescribing at a glance /
حسب: Ross, Sarah (Clinical pharmacologist)
منشور في: (2014)

Clinical drug therapy : rationales for nursing practice /
حسب: Abrams, Anne Collins
منشور في: (1995)

Principles of clinical pharmacology
منشور في: (2007)

Forecasting for the pharmaceutical industry models for new product and in-market forecasting and how to use them /
حسب: Cook, Arthur G.
منشور في: (2006)

High-throughput screening methods in toxicity testing
منشور في: (2013)

Drugs, behavior, and modern society /
حسب: Levinthal, Charles F, 1945-
منشور في: (2014)